Request Demo
Recent blog posts
Latest Hotspot
8 min read
Mastocytosis Indication Strategy Report 2026: c-Kit, Trials and Deals
23 July 2026
2026 Mastocytosis strategy: epidemiology, c-Kit biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized with…
Latest Hotspot
8 min read
Achalasia Indication Strategy Report 2026: nNOS, Trials and Deals
23 July 2026
2026 Achalasia strategy: epidemiology, nNOS biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized with PatSnap…
Latest Hotspot
8 min read
Lymphocytic esophagitis Indication Strategy Report 2026: IL-13, Trials and Deals
23 July 2026
2026 Lymphocytic esophagitis strategy: epidemiology, IL-13 biology, clinical competition, recent deals, unmet need and market attractiveness.
Latest Hotspot
8 min read
Darier disease Indication Strategy Report 2026: ATP2A2, Trials and Deals
23 July 2026
2026 Darier disease strategy: epidemiology, ATP2A2 biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized with…
Latest Hotspot
8 min read
Hailey-Hailey disease Indication Strategy Report 2026: ATP2C1, Trials and Deals
23 July 2026
2026 Hailey-Hailey disease strategy: epidemiology, ATP2C1 biology, clinical competition, recent deals, unmet need and market attractiveness.
Latest Hotspot
8 min read
Netherton syndrome Indication Strategy Report 2026: KLK5, Trials and Deals
23 July 2026
2026 Netherton syndrome strategy: epidemiology, KLK5 biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized with…
Latest Hotspot
8 min read
Lamellar ichthyosis Indication Strategy Report 2026: TGM1, Trials and Deals
23 July 2026
2026 Lamellar ichthyosis strategy: epidemiology, TGM1 biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized…
Latest Hotspot
8 min read
X-linked ichthyosis Indication Strategy Report 2026: STS, Trials and Deals
23 July 2026
2026 X-linked ichthyosis strategy: epidemiology, STS biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized with…
Latest Hotspot
8 min read
Ichthyosis vulgaris Indication Strategy Report 2026: FLG, Trials and Deals
23 July 2026
2026 Ichthyosis vulgaris strategy: epidemiology, FLG biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized with…
Latest Hotspot
8 min read
Junctional epidermolysis bullosa Indication Strategy Report 2026: LAMB3, Trials and Deals
23 July 2026
2026 Junctional epidermolysis bullosa strategy: epidemiology, LAMB3 biology, clinical competition, recent deals, unmet need and market attractiveness.
Latest Hotspot
8 min read
Dystrophic epidermolysis bullosa Indication Strategy Report 2026: COL7A1, Trials and Deals
23 July 2026
2026 Dystrophic epidermolysis bullosa strategy: epidemiology, COL7A1 biology, clinical competition, recent deals, unmet need and market attractiveness.
Latest Hotspot
8 min read
Epidermolysis bullosa Indication Strategy Report 2026: COL7A1, Trials and Deals
23 July 2026
2026 Epidermolysis bullosa strategy: epidemiology, COL7A1 biology, clinical competition, recent deals, unmet need and market attractiveness.